Alnylam Pharmaceuticals, Inc.

ALNY·NasdaqGS
Compare
227.02−5.66 (−2.43%)today
At close: Oct 12, 4:00 PM EDT · May be delayed up to 15 min · USD
After hours226.00−1.02 (−0.45%)Oct 12, 4:18 PM EDT

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close232.68
Open233.60
Day range226.65233.60
52-week range197.81495.55
Off day high−2.82%
Off 52-week high−54.19%
Volume916.85K
Avg. volume (3M)1.74M
Market cap30.38B
EPS (TTM)5.93
Forward P/E18.28
P/E ratio (TTM)38.28
Dividend yield—
Beta (5Y)—
Shares outstanding133.81M
Short interest—
Earnings dateJul 30, 2026 (est.)
Analyst target—
Profit margin—

Against its peers

Compare in full ›
ALNY ARWR IONS BBIO ROIV REGN
Market cap 30.38B 8.58B 7.26B 12.85B 24.99B 78.54B
P/E (TTM) 38.3 — — — — 18.9
Forward P/E 18.3 -12.3 -39.3 2,275.1 -20.1 12.4
Price/book 22.4 18.4 16.4 -5.1 5.9 2.4
Dividend yield — — — — — 0.50%
1-year change −51.17% +68.88% −35.85% +16.37% +118.63% +33.85%
Today −2.43% −3.22% −3.56% +0.61% −2.40% +2.18%

The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.

Latest news

All ALNY news ›

No recent coverage in the 4Search index.

From articles in the 4Search news index.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Conservative index. Terms of use.